Media Releases
We will continuously advance, bringing diseases early detection technology to the general public. From Hong Kong to the world, please follow us and witness our ongoing progress.
Chemmino took part in Pitch Event 1 of MedTech Innovator Asia Pacific’s 2026 RoadTour on 5 March. The virtual event brought together nine medtech startups from across Asia Pacific for investor, strategic-partner and expert engagement.
The team presented its in-development portable optical-sensing approach to cancer-risk assessment. The product concept combines luminescent metal compounds that respond to DNA damage, a miniature spectral sensor, mobile connectivity and AI-assisted analysis.
Chemmino is building the platform around a simple, non-invasive user experience centred on saliva-based testing. The pitch gave the team an opportunity to discuss the product direction with medtech investors, strategic partners and healthcare experts in the region.